Fumagalli, Giorgio Giulio
 Distribuzione geografica
Continente #
EU - Europa 539
NA - Nord America 397
AS - Asia 76
OC - Oceania 10
AF - Africa 2
SA - Sud America 1
Totale 1.025
Nazione #
IT - Italia 380
US - Stati Uniti d'America 380
GB - Regno Unito 120
SG - Singapore 43
CA - Canada 17
CN - Cina 15
FI - Finlandia 15
AU - Australia 10
HK - Hong Kong 10
DE - Germania 6
AT - Austria 3
FR - Francia 3
IN - India 3
SE - Svezia 3
BG - Bulgaria 2
CH - Svizzera 2
GH - Ghana 2
IE - Irlanda 2
QA - Qatar 2
BR - Brasile 1
GE - Georgia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NL - Olanda 1
PL - Polonia 1
SA - Arabia Saudita 1
Totale 1.025
Città #
Trento 299
Ashburn 235
Washington 56
London 51
Singapore 21
New York 20
Milan 16
Los Angeles 13
Bassano del Grappa 11
Hong Kong 10
Lappeenranta 9
Seattle 9
Ottawa 8
Kilburn 7
Brisbane 6
Dongguan 6
Helsinki 6
Islington 6
New Bedfont 6
Rome 6
Acton 5
Prescot 5
Newham 4
Reggio Emilia 4
Ancona 3
Fairfax 3
Florence 3
Frankfurt am Main 3
Mississauga 3
Montichiari 3
Sydney 3
Tappahannock 3
Bathgate 2
Bengaluru 2
Biancavilla 2
Boardman 2
Bournemouth 2
Carugate 2
Chicago 2
Doha 2
Dublin 2
East Dulwich 2
Fayetteville 2
Genoa 2
Honolulu 2
Lewes 2
Manchester 2
Milton Keynes 2
Ningbo 2
Paris 2
Pavia 2
Pianiga 2
San Marzano Oliveto 2
Sofia 2
Southwark 2
Stourbridge 2
Uppsala 2
Zurich 2
Amsterdam 1
Bethnal Green 1
Birmingham 1
Brentford 1
Catania 1
Chandigarh 1
Chiswick 1
Colombo 1
Council Bluffs 1
Cunevo 1
Ferrara 1
Greenwich 1
Hamm 1
Hounslow 1
Luxembourg 1
Mannheim 1
Munich 1
Nanping 1
New Haven 1
Oakland 1
Perth 1
Phoenix 1
Princeton 1
Riyadh 1
San Daniele del Friuli 1
Sandston 1
Sankt Veit an der Goelsen 1
Sanming 1
Santa Clara 1
Siena 1
Tbilisi 1
The Dalles 1
Vienna 1
Wandsworth 1
Wigan 1
Ziebice 1
Örebro 1
Totale 932
Nome #
The search for a link between autism spectrum disorder and neurodegenerative dementia 76
The Italian fund for Alzheimer's and other dementias: strategies and objectives to face the dementia challenge 24
MiRNA Profiling in Plasma Neural-Derived Small Extracellular Vesicles from Patients with Alzheimer's Disease 24
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study 21
Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort 21
Brain functional network integrity sustains cognitive function despite atrophy in presymptomatic genetic frontotemporal dementia 20
Caregiver Tele-Assistance for Reduction of Emotional Distress during the COVID-19 Pandemic. Psychological Support to Caregivers of People with Dementia: The Italian Experience 20
Analysis of brain atrophy and local gene expression in genetic frontotemporal dementia 18
Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study 18
Comparison of arterial spin labeling registration strategies in the multi-center GENetic frontotemporal dementia initiative (GENFI) 17
Association of Superficial White Matter Alterations with Cerebrospinal Fluid Biomarkers and Cognitive Decline in Neurodegenerative Dementia 16
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study 15
Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference 15
CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia 15
Quantitative susceptibility mapping of the normal-appearing white matter as a potential new marker of disability progression in multiple sclerosis 15
Practice effects in genetic frontotemporal dementia and at-risk individuals: a GENFI study 15
Disease-related cortical thinning in presymptomatic granulin mutation carriers 15
Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study 14
Accuracy of the clinical diagnosis of dementia with Lewy bodies (DLB) among the Italian Dementia Centers: a study by the Italian DLB study group (DLB-SINdem) 14
Cognitive composites for genetic frontotemporal dementia: GENFI-Cog 14
Aquaporin-4 cerebrospinal fluid levels are higher in neurodegenerative dementia: looking at glymphatic system dysregulation 14
Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: From biological biomarkers to clinical syndromes 14
Alemtuzumab in multiple sclerosis during the COVID-19 pandemic: A mild uncomplicated infection despite intense immunosuppression 14
A modified Camel and Cactus Test detects presymptomatic semantic impairment in genetic frontotemporal dementia within the GENFI cohort 14
miRNA Expression Is Increased in Serum from Patients with Semantic Variant Primary Progressive Aphasia 14
Facing the digital divide into a dementia clinic during COVID-19 pandemic: caregiver age matters 14
Spatiotemporal analysis for detection of pre-symptomatic shape changes in neurodegenerative diseases: Initial application to the GENFI cohort 14
Low CSF β-amyloid levels predict early regional grey matter atrophy in multiple sclerosis 14
The CBI-R detects early behavioural impairment in genetic frontotemporal dementia 13
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia 13
CSF β-amyloid and white matter damage: A new perspective on Alzheimer's disease 13
Utility of visual rating scales in primary progressive aphasia 13
Data-driven staging of genetic frontotemporal dementia using multi-modal MRI 13
Clinical features and disease course of patients with acute ischaemic stroke just before the Italian index case: Was COVID-19 already there? 13
Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia 13
Tango and physiotherapy interventions in Parkinson’s disease: a pilot study on efficacy outcomes on motor and cognitive skills 13
A Novel Automated Chemiluminescence Method for Detecting Cerebrospinal Fluid Amyloid-Beta 1-42 and 1-40, Total Tau and Phosphorylated-Tau: Implications for Improving Diagnostic Performance in Alzheimer’s Disease 13
White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study 12
Parieto-occipital sulcus widening differentiates posterior cortical atrophy from typical Alzheimer disease 12
Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia 12
Teaching NeuroImage: Crowned Dens Syndrome: An Acute Attack of Calcium Pyrophosphate Deposition Disease Mimicking Acute Meningitis 12
Behavioral and neurophysiological effects of transcranial direct current stimulation (tDCS) in fronto-temporal dementia 12
Differential early subcortical involvement in genetic FTD within the GENFI cohort 12
MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia 12
Impairment of episodic memory in genetic frontotemporal dementia: A GENFI study 12
Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes 12
Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort 12
Structural brain splitting is a hallmark of Granulin-related frontotemporal dementia 12
The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients 12
Hierarchical spectral clustering reveals brain size and shape changes in asymptomatic carriers of C9orf72 12
A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study 12
Amyloid PET imaging and dementias: potential applications in detecting and quantifying early white matter damage 12
Detection of the SQSTM1 Mutation in a Patient with Early-Onset Hippocampal Amnestic Syndrome 12
An Automated Toolbox to Predict Single Subject Atrophy in Presymptomatic Granulin Mutation Carriers 11
Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease? 11
Crossing Borders between Frontotemporal Dementia and Psychiatric Disorders: An Updated Overview 11
Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study 11
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 11
Progression of Behavioral Disturbances and Neuropsychiatric Symptoms in Patients with Genetic Frontotemporal Dementia 11
Diogenes syndrome in dementia: a case report 11
Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: A cross-sectional analysis 11
Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales 10
Diagnosis of Frontotemporal Dementia 10
Profiling of specific gene expression pathways in peripheral cells from prodromal Alzheimer's disease patients 10
Monozygotic Twins with Frontotemporal Dementia Due to Thr272fs GRN Mutation Discordant for Age at Onset 10
Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: A GENFI study 10
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 10
Word and Picture Version of the Free and Cued Selective Reminding Test (FCSRT): Is There Any Difference? 10
Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations 10
Niemann-Pick Type C 1 (NPC1) and NPC2 gene variability in demented patients with evidence of brain amyloid deposition 10
Temporal order of clinical and biomarker changes in familial frontotemporal dementia 10
Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia 10
Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales 9
Unravelling the Association between Amyloid-PET and Cerebrospinal Fluid Biomarkers in the Alzheimer's Disease Spectrum: Who Really Deserves an A+? 9
CSF β-amyloid predicts prognosis in patients with multiple sclerosis 9
Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia 9
Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia: GENFI results 9
Alzheimer's disease diagnosis: Discrepancy between clinical, neuroimaging, and cerebrospinal fluid biomarkers criteria in an Italian cohort of geriatric outpatients: A retrospective cross-sectional study 9
Analysis of C9orf72 Intermediate Alleles in a Retrospective Cohort of Neurological Patients: Risk Factors for Alzheimer's Disease? 9
Faster Cortical Thinning and Surface Area Loss in Presymptomatic and Symptomatic C9orf72 Repeat Expansion Adult Carriers 9
null 9
Evidence of retinal anterograde neurodegeneration in the very early stages of multiple sclerosis : a longitudinal OCT study 8
Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative cohort 8
Modelling the cascade of biomarker changes in GRN-related frontotemporal dementia 8
The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort 8
Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis 8
Altered plasma protein profiles in genetic FTD - a GENFI study 8
Neurodevelopmental effects of genetic frontotemporal dementia in young adult mutation carriers 8
Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: A GENFI study 8
Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study 8
Plasma microglial-derived extracellular vesicles are increased in frail patients with Mild Cognitive Impairment and exert a neurotoxic effect 8
Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementia 7
Predominant right temporal lobe atrophy: Clinical, neuropsychological and structural differences based on amyloid status 7
Early symptoms in symptomatic and preclinical genetic frontotemporal lobar degeneration 7
Association between enlarged perivascular spaces and cerebrospinal fluid aquaporin-4 and tau levels: report from a memory clinic 7
Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: A GENFI study 7
Inflammatory expression profile in peripheral blood mononuclear cells from patients with Nasu-Hakola Disease 7
CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis 7
Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort 7
Neuropsychiatric symptoms in genetic frontotemporal dementia: developing a new module for Clinical Rating Scales 7
Totale 1.250
Categoria #
all - tutte 23.194
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 243
Totale 23.437


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023528 0 0 0 50 255 99 26 26 25 5 10 32
2023/2024879 5 12 77 30 78 215 161 91 10 87 68 45
Totale 1.407